Innovent Biologics, Inc.

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, NONOF has a market cap of 182.9B. Regarding current trading prices, IVBXF is priced at $11.45, while NONOF trades at $41.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas NONOF's P/E ratio is 11.34. In terms of profitability, IVBXF's ROE is +0.05%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, IVBXF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check NONOF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, CSLLY has a market cap of 91B. Regarding current trading prices, IVBXF is priced at $11.45, while CSLLY trades at $23.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas CSLLY's P/E ratio is 15.26. In terms of profitability, IVBXF's ROE is +0.05%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, IVBXF is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check CSLLY's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, ARGNF has a market cap of 55.4B. Regarding current trading prices, IVBXF is priced at $11.45, while ARGNF trades at $894.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas ARGNF's P/E ratio is 45.65. In terms of profitability, IVBXF's ROE is +0.05%, compared to ARGNF's ROE of +0.34%. Regarding short-term risk, IVBXF is less volatile compared to ARGNF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check ARGNF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, UCBJF has a market cap of 54.3B. Regarding current trading prices, IVBXF is priced at $11.45, while UCBJF trades at $285.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas UCBJF's P/E ratio is 30.32. In terms of profitability, IVBXF's ROE is +0.05%, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, IVBXF and UCBJF have similar daily volatility (0.00).Check UCBJF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, UCBJY has a market cap of 53.1B. Regarding current trading prices, IVBXF is priced at $11.45, while UCBJY trades at $139.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas UCBJY's P/E ratio is 29.70. In terms of profitability, IVBXF's ROE is +0.05%, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, IVBXF is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check UCBJY's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, CMXHF has a market cap of 45.1B. Regarding current trading prices, IVBXF is priced at $11.45, while CMXHF trades at $95.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas CMXHF's P/E ratio is 15.06. In terms of profitability, IVBXF's ROE is +0.05%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, IVBXF is less volatile compared to CMXHF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check CMXHF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, WXIBF has a market cap of 21.7B. Regarding current trading prices, IVBXF is priced at $11.45, while WXIBF trades at $5.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas WXIBF's P/E ratio is 30.88. In terms of profitability, IVBXF's ROE is +0.05%, compared to WXIBF's ROE of +0.11%. Regarding short-term risk, IVBXF is less volatile compared to WXIBF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check WXIBF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, WXXWY has a market cap of 17.7B. Regarding current trading prices, IVBXF is priced at $11.45, while WXXWY trades at $8.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas WXXWY's P/E ratio is 25.15. In terms of profitability, IVBXF's ROE is +0.05%, compared to WXXWY's ROE of +0.11%. Regarding short-term risk, IVBXF is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check WXXWY's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, GNMSF has a market cap of 17.4B. Regarding current trading prices, IVBXF is priced at $11.45, while GNMSF trades at $281.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas GNMSF's P/E ratio is 18.34. In terms of profitability, IVBXF's ROE is +0.05%, compared to GNMSF's ROE of +0.19%. Regarding short-term risk, IVBXF and GNMSF have similar daily volatility (0.00).Check GNMSF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, SBMFF has a market cap of 13.6B. Regarding current trading prices, IVBXF is priced at $11.45, while SBMFF trades at $0.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas SBMFF's P/E ratio is 25.33. In terms of profitability, IVBXF's ROE is +0.05%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, IVBXF and SBMFF have similar daily volatility (0.00).Check SBMFF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, SBHMY has a market cap of 12.8B. Regarding current trading prices, IVBXF is priced at $11.45, while SBHMY trades at $14.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas SBHMY's P/E ratio is 37.59. In terms of profitability, IVBXF's ROE is +0.05%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, IVBXF and SBHMY have similar daily volatility (0.00).Check SBHMY's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, IVBXF is priced at $11.45, while BRRGF trades at $97.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, IVBXF's ROE is +0.05%, compared to BRRGF's ROE of -0.97%. Regarding short-term risk, IVBXF is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check BRRGF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, AAVXF has a market cap of 9.2B. Regarding current trading prices, IVBXF is priced at $11.45, while AAVXF trades at $115.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas AAVXF's P/E ratio is -22.11. In terms of profitability, IVBXF's ROE is +0.05%, compared to AAVXF's ROE of -1.65%. Regarding short-term risk, IVBXF and AAVXF have similar daily volatility (0.00).Check AAVXF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, IVBXF is priced at $11.45, while ODTC trades at $22,005.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas ODTC's P/E ratio is 1.07. In terms of profitability, IVBXF's ROE is +0.05%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, IVBXF and ODTC have similar daily volatility (0.00).Check ODTC's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, TRSBF has a market cap of 7.1B. Regarding current trading prices, IVBXF is priced at $11.45, while TRSBF trades at $3.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas TRSBF's P/E ratio is 21.43. In terms of profitability, IVBXF's ROE is +0.05%, compared to TRSBF's ROE of +0.38%. Regarding short-term risk, IVBXF and TRSBF have similar daily volatility (0.00).Check TRSBF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, AKBLF has a market cap of 6.3B. Regarding current trading prices, IVBXF is priced at $11.45, while AKBLF trades at $31.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas AKBLF's P/E ratio is 36.88. In terms of profitability, IVBXF's ROE is +0.05%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, IVBXF and AKBLF have similar daily volatility (0.00).Check AKBLF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, REGMF has a market cap of 5.5B. Regarding current trading prices, IVBXF is priced at $11.45, while REGMF trades at $9.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas REGMF's P/E ratio is 51.63. In terms of profitability, IVBXF's ROE is +0.05%, compared to REGMF's ROE of +0.27%. Regarding short-term risk, IVBXF and REGMF have similar daily volatility (0.00).Check REGMF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, IVBXF is priced at $11.45, while ABCZF trades at $22.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, IVBXF and ABCZF have similar daily volatility (0.00).Check ABCZF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, IVBXF is priced at $11.45, while LABFF trades at $90.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas LABFF's P/E ratio is 28.95. In terms of profitability, IVBXF's ROE is +0.05%, compared to LABFF's ROE of +0.23%. Regarding short-term risk, IVBXF and LABFF have similar daily volatility (0.00).Check LABFF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, SHJBF has a market cap of 4.3B. Regarding current trading prices, IVBXF is priced at $11.45, while SHJBF trades at $3.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas SHJBF's P/E ratio is -25.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to SHJBF's ROE of -0.14%. Regarding short-term risk, IVBXF is less volatile compared to SHJBF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check SHJBF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, ZLDPF has a market cap of 3.6B. Regarding current trading prices, IVBXF is priced at $11.45, while ZLDPF trades at $50.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas ZLDPF's P/E ratio is 3.60. In terms of profitability, IVBXF's ROE is +0.05%, compared to ZLDPF's ROE of +0.48%. Regarding short-term risk, IVBXF is less volatile compared to ZLDPF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check ZLDPF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, TLPPF has a market cap of 3.4B. Regarding current trading prices, IVBXF is priced at $11.45, while TLPPF trades at $9.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas TLPPF's P/E ratio is -499.50. In terms of profitability, IVBXF's ROE is +0.05%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, IVBXF is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check TLPPF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, BRCTF has a market cap of 3.4B. Regarding current trading prices, IVBXF is priced at $11.45, while BRCTF trades at $38.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas BRCTF's P/E ratio is 30.40. In terms of profitability, IVBXF's ROE is +0.05%, compared to BRCTF's ROE of +0.52%. Regarding short-term risk, IVBXF and BRCTF have similar daily volatility (0.00).Check BRCTF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, CAMRF has a market cap of 3.3B. Regarding current trading prices, IVBXF is priced at $11.45, while CAMRF trades at $55.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas CAMRF's P/E ratio is 41.35. In terms of profitability, IVBXF's ROE is +0.05%, compared to CAMRF's ROE of +0.19%. Regarding short-term risk, IVBXF and CAMRF have similar daily volatility (0.00).Check CAMRF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, ASPHF has a market cap of 3.2B. Regarding current trading prices, IVBXF is priced at $11.45, while ASPHF trades at $8.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas ASPHF's P/E ratio is -16.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to ASPHF's ROE of -0.73%. Regarding short-term risk, IVBXF and ASPHF have similar daily volatility (0.00).Check ASPHF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, INCPF has a market cap of 3.1B. Regarding current trading prices, IVBXF is priced at $11.45, while INCPF trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas INCPF's P/E ratio is 34.17. In terms of profitability, IVBXF's ROE is +0.05%, compared to INCPF's ROE of +0.10%. Regarding short-term risk, IVBXF is less volatile compared to INCPF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check INCPF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, GNNSF has a market cap of 3.1B. Regarding current trading prices, IVBXF is priced at $11.45, while GNNSF trades at $1.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas GNNSF's P/E ratio is -5.60. In terms of profitability, IVBXF's ROE is +0.05%, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, IVBXF and GNNSF have similar daily volatility (0.00).Check GNNSF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, IVBXF is priced at $11.45, while MPSYF trades at $73.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, IVBXF's ROE is +0.05%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, IVBXF is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check MPSYF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, ASCLF has a market cap of 2.5B. Regarding current trading prices, IVBXF is priced at $11.45, while ASCLF trades at $2.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas ASCLF's P/E ratio is -47.12. In terms of profitability, IVBXF's ROE is +0.05%, compared to ASCLF's ROE of -0.19%. Regarding short-term risk, IVBXF is less volatile compared to ASCLF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check ASCLF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, BVNKF has a market cap of 2.4B. Regarding current trading prices, IVBXF is priced at $11.45, while BVNKF trades at $30.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas BVNKF's P/E ratio is 11.12. In terms of profitability, IVBXF's ROE is +0.05%, compared to BVNKF's ROE of +0.11%. Regarding short-term risk, IVBXF and BVNKF have similar daily volatility (0.00).Check BVNKF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, GENSF has a market cap of 2.3B. Regarding current trading prices, IVBXF is priced at $11.45, while GENSF trades at $35.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas GENSF's P/E ratio is 36.46. In terms of profitability, IVBXF's ROE is +0.05%, compared to GENSF's ROE of +0.10%. Regarding short-term risk, IVBXF and GENSF have similar daily volatility (0.00).Check GENSF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, BVNRY has a market cap of 2.3B. Regarding current trading prices, IVBXF is priced at $11.45, while BVNRY trades at $9.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas BVNRY's P/E ratio is 10.59. In terms of profitability, IVBXF's ROE is +0.05%, compared to BVNRY's ROE of +0.11%. Regarding short-term risk, IVBXF is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check BVNRY's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, MEOBF has a market cap of 2.2B. Regarding current trading prices, IVBXF is priced at $11.45, while MEOBF trades at $1.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas MEOBF's P/E ratio is -24.29. In terms of profitability, IVBXF's ROE is +0.05%, compared to MEOBF's ROE of -0.14%. Regarding short-term risk, IVBXF and MEOBF have similar daily volatility (0.00).Check MEOBF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, HBMHF has a market cap of 2.1B. Regarding current trading prices, IVBXF is priced at $11.45, while HBMHF trades at $2.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas HBMHF's P/E ratio is 28.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to HBMHF's ROE of +0.36%. Regarding short-term risk, IVBXF and HBMHF have similar daily volatility (0.00).Check HBMHF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, GLPGF has a market cap of 1.9B. Regarding current trading prices, IVBXF is priced at $11.45, while GLPGF trades at $28.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas GLPGF's P/E ratio is -3.50. In terms of profitability, IVBXF's ROE is +0.05%, compared to GLPGF's ROE of +0.11%. Regarding short-term risk, IVBXF and GLPGF have similar daily volatility (0.00).Check GLPGF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, PHMMF has a market cap of 1.8B. Regarding current trading prices, IVBXF is priced at $11.45, while PHMMF trades at $106.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas PHMMF's P/E ratio is 46.29. In terms of profitability, IVBXF's ROE is +0.05%, compared to PHMMF's ROE of +0.35%. Regarding short-term risk, IVBXF and PHMMF have similar daily volatility (0.00).Check PHMMF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, ONTTF has a market cap of 1.7B. Regarding current trading prices, IVBXF is priced at $11.45, while ONTTF trades at $1.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas ONTTF's P/E ratio is -8.85. In terms of profitability, IVBXF's ROE is +0.05%, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, IVBXF is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check ONTTF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, IVBXF is priced at $11.45, while BIESF trades at $32.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas BIESF's P/E ratio is -44.44. In terms of profitability, IVBXF's ROE is +0.05%, compared to BIESF's ROE of -0.05%. Regarding short-term risk, IVBXF and BIESF have similar daily volatility (0.00).Check BIESF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, CSPHF has a market cap of 1.4B. Regarding current trading prices, IVBXF is priced at $11.45, while CSPHF trades at $0.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas CSPHF's P/E ratio is -17.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to CSPHF's ROE of -0.64%. Regarding short-term risk, IVBXF and CSPHF have similar daily volatility (0.00).Check CSPHF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, IVBXF is priced at $11.45, while SNBIF trades at $16.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, IVBXF's ROE is +0.05%, compared to SNBIF's ROE of -0.89%. Regarding short-term risk, IVBXF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check SNBIF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, IVBXF is priced at $11.45, while MDCLF trades at $34.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, IVBXF's ROE is +0.05%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, IVBXF and MDCLF have similar daily volatility (0.00).Check MDCLF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, PHGUF has a market cap of 1.2B. Regarding current trading prices, IVBXF is priced at $11.45, while PHGUF trades at $1.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas PHGUF's P/E ratio is -170.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to PHGUF's ROE of +0.01%. Regarding short-term risk, IVBXF and PHGUF have similar daily volatility (0.00).Check PHGUF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, CSBTF has a market cap of 1.1B. Regarding current trading prices, IVBXF is priced at $11.45, while CSBTF trades at $28.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas CSBTF's P/E ratio is 350.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, IVBXF and CSBTF have similar daily volatility (0.00).Check CSBTF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, IDRSF has a market cap of 1.1B. Regarding current trading prices, IVBXF is priced at $11.45, while IDRSF trades at $4.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas IDRSF's P/E ratio is -6.55. In terms of profitability, IVBXF's ROE is +0.05%, compared to IDRSF's ROE of +0.10%. Regarding short-term risk, IVBXF is less volatile compared to IDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check IDRSF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, NURPF has a market cap of 1B. Regarding current trading prices, IVBXF is priced at $11.45, while NURPF trades at $8.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas NURPF's P/E ratio is 48.35. In terms of profitability, IVBXF's ROE is +0.05%, compared to NURPF's ROE of +0.09%. Regarding short-term risk, IVBXF and NURPF have similar daily volatility (0.00).Check NURPF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, PPTDF has a market cap of 1B. Regarding current trading prices, IVBXF is priced at $11.45, while PPTDF trades at $7.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas PPTDF's P/E ratio is -43.06. In terms of profitability, IVBXF's ROE is +0.05%, compared to PPTDF's ROE of -0.03%. Regarding short-term risk, IVBXF and PPTDF have similar daily volatility (0.00).Check PPTDF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, IVBXF is priced at $11.45, while BTTAY trades at $24.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, IVBXF's ROE is +0.05%, compared to BTTAY's ROE of -0.05%. Regarding short-term risk, IVBXF is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check BTTAY's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, IVBXF is priced at $11.45, while TKBIF trades at $7.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas TKBIF's P/E ratio is -22.12. In terms of profitability, IVBXF's ROE is +0.05%, compared to TKBIF's ROE of N/A. Regarding short-term risk, IVBXF is less volatile compared to TKBIF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check TKBIF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, BPMUF has a market cap of 846.9M. Regarding current trading prices, IVBXF is priced at $11.45, while BPMUF trades at $69.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas BPMUF's P/E ratio is 9.69. In terms of profitability, IVBXF's ROE is +0.05%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, IVBXF and BPMUF have similar daily volatility (0.00).Check BPMUF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, IVEVF has a market cap of 764.8M. Regarding current trading prices, IVBXF is priced at $11.45, while IVEVF trades at $5.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas IVEVF's P/E ratio is -2.48. In terms of profitability, IVBXF's ROE is +0.05%, compared to IVEVF's ROE of +18.92%. Regarding short-term risk, IVBXF and IVEVF have similar daily volatility (0.00).Check IVEVF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, VBIZF has a market cap of 622.3M. Regarding current trading prices, IVBXF is priced at $11.45, while VBIZF trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas VBIZF's P/E ratio is 29.50. In terms of profitability, IVBXF's ROE is +0.05%, compared to VBIZF's ROE of +0.06%. Regarding short-term risk, IVBXF and VBIZF have similar daily volatility (0.00).Check VBIZF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, IVBXF is priced at $11.45, while CKDXF trades at $0.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, IVBXF's ROE is +0.05%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, IVBXF is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check CKDXF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, SOLTF has a market cap of 570.1M. Regarding current trading prices, IVBXF is priced at $11.45, while SOLTF trades at $6.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas SOLTF's P/E ratio is -7.24. In terms of profitability, IVBXF's ROE is +0.05%, compared to SOLTF's ROE of -0.19%. Regarding short-term risk, IVBXF is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check SOLTF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, GNFTF has a market cap of 553.4M. Regarding current trading prices, IVBXF is priced at $11.45, while GNFTF trades at $11.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas GNFTF's P/E ratio is -5.50. In terms of profitability, IVBXF's ROE is +0.05%, compared to GNFTF's ROE of -5.96%. Regarding short-term risk, IVBXF is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check GNFTF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, INRLF has a market cap of 481.8M. Regarding current trading prices, IVBXF is priced at $11.45, while INRLF trades at $2.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas INRLF's P/E ratio is -3.50. In terms of profitability, IVBXF's ROE is +0.05%, compared to INRLF's ROE of -0.75%. Regarding short-term risk, IVBXF and INRLF have similar daily volatility (0.00).Check INRLF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, AVCTF has a market cap of 461.5M. Regarding current trading prices, IVBXF is priced at $11.45, while AVCTF trades at $1.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas AVCTF's P/E ratio is -7.03. In terms of profitability, IVBXF's ROE is +0.05%, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, IVBXF and AVCTF have similar daily volatility (0.00).Check AVCTF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, IVBXF is priced at $11.45, while RAONF trades at $2.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas RAONF's P/E ratio is -43.33. In terms of profitability, IVBXF's ROE is +0.05%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, IVBXF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check RAONF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, IVBXF is priced at $11.45, while GNFTY trades at $8.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, IVBXF's ROE is +0.05%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, IVBXF is less volatile compared to GNFTY. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check GNFTY's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, CYDY has a market cap of 437.1M. Regarding current trading prices, IVBXF is priced at $11.45, while CYDY trades at $0.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas CYDY's P/E ratio is -8.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to CYDY's ROE of +0.37%. Regarding short-term risk, IVBXF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check CYDY's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, BOVNF has a market cap of 436.3M. Regarding current trading prices, IVBXF is priced at $11.45, while BOVNF trades at $6.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas BOVNF's P/E ratio is -14.11. In terms of profitability, IVBXF's ROE is +0.05%, compared to BOVNF's ROE of -0.47%. Regarding short-term risk, IVBXF is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check BOVNF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, IVBXF is priced at $11.45, while TBGNF trades at $0.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, IVBXF's ROE is +0.05%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, IVBXF and TBGNF have similar daily volatility (0.00).Check TBGNF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, NWPHF has a market cap of 399.3M. Regarding current trading prices, IVBXF is priced at $11.45, while NWPHF trades at $20.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas NWPHF's P/E ratio is N/A. In terms of profitability, IVBXF's ROE is +0.05%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, IVBXF is less volatile compared to NWPHF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check NWPHF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, PTCHF has a market cap of 379.7M. Regarding current trading prices, IVBXF is priced at $11.45, while PTCHF trades at $1.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas PTCHF's P/E ratio is 9.18. In terms of profitability, IVBXF's ROE is +0.05%, compared to PTCHF's ROE of +0.13%. Regarding short-term risk, IVBXF and PTCHF have similar daily volatility (0.00).Check PTCHF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, SLNCF has a market cap of 334.4M. Regarding current trading prices, IVBXF is priced at $11.45, while SLNCF trades at $2.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas SLNCF's P/E ratio is -3.75. In terms of profitability, IVBXF's ROE is +0.05%, compared to SLNCF's ROE of -3.59%. Regarding short-term risk, IVBXF and SLNCF have similar daily volatility (0.00).Check SLNCF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, CLVLY has a market cap of 334M. Regarding current trading prices, IVBXF is priced at $11.45, while CLVLY trades at $6.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas CLVLY's P/E ratio is 14.40. In terms of profitability, IVBXF's ROE is +0.05%, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, IVBXF and CLVLY have similar daily volatility (0.00).Check CLVLY's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, SPHDF has a market cap of 324.9M. Regarding current trading prices, IVBXF is priced at $11.45, while SPHDF trades at $22.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas SPHDF's P/E ratio is -3.34. In terms of profitability, IVBXF's ROE is +0.05%, compared to SPHDF's ROE of -5.22%. Regarding short-term risk, IVBXF and SPHDF have similar daily volatility (0.00).Check SPHDF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, CLVLF has a market cap of 316.1M. Regarding current trading prices, IVBXF is priced at $11.45, while CLVLF trades at $6.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas CLVLF's P/E ratio is 12.54. In terms of profitability, IVBXF's ROE is +0.05%, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, IVBXF and CLVLF have similar daily volatility (0.00).Check CLVLF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, NGENF has a market cap of 312.9M. Regarding current trading prices, IVBXF is priced at $11.45, while NGENF trades at $3.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas NGENF's P/E ratio is -15.19. In terms of profitability, IVBXF's ROE is +0.05%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, IVBXF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check NGENF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, NWBO has a market cap of 310.1M. Regarding current trading prices, IVBXF is priced at $11.45, while NWBO trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas NWBO's P/E ratio is -4.83. In terms of profitability, IVBXF's ROE is +0.05%, compared to NWBO's ROE of +0.71%. Regarding short-term risk, IVBXF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check NWBO's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, FGHQF has a market cap of 304.2M. Regarding current trading prices, IVBXF is priced at $11.45, while FGHQF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas FGHQF's P/E ratio is 15.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to FGHQF's ROE of +0.02%. Regarding short-term risk, IVBXF and FGHQF have similar daily volatility (0.00).Check FGHQF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, HLOSF has a market cap of 290.7M. Regarding current trading prices, IVBXF is priced at $11.45, while HLOSF trades at $2.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas HLOSF's P/E ratio is -15.88. In terms of profitability, IVBXF's ROE is +0.05%, compared to HLOSF's ROE of -0.80%. Regarding short-term risk, IVBXF and HLOSF have similar daily volatility (0.00).Check HLOSF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, IVBXF is priced at $11.45, while PBBIF trades at $24.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, IVBXF's ROE is +0.05%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, IVBXF and PBBIF have similar daily volatility (0.00).Check PBBIF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, IVBXF is priced at $11.45, while ORPOF trades at $11.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, IVBXF's ROE is +0.05%, compared to ORPOF's ROE of N/A. Regarding short-term risk, IVBXF and ORPOF have similar daily volatility (0.00).Check ORPOF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, IVBXF is priced at $11.45, while HNSBF trades at $2.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas HNSBF's P/E ratio is -4.08. In terms of profitability, IVBXF's ROE is +0.05%, compared to HNSBF's ROE of +2.02%. Regarding short-term risk, IVBXF is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check HNSBF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, OPORF has a market cap of 240.9M. Regarding current trading prices, IVBXF is priced at $11.45, while OPORF trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas OPORF's P/E ratio is 35.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to OPORF's ROE of -0.15%. Regarding short-term risk, IVBXF and OPORF have similar daily volatility (0.00).Check OPORF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, ORYZF has a market cap of 234.9M. Regarding current trading prices, IVBXF is priced at $11.45, while ORYZF trades at $3.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas ORYZF's P/E ratio is -75.75. In terms of profitability, IVBXF's ROE is +0.05%, compared to ORYZF's ROE of -0.03%. Regarding short-term risk, IVBXF and ORYZF have similar daily volatility (0.00).Check ORYZF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, CMVLF has a market cap of 222.8M. Regarding current trading prices, IVBXF is priced at $11.45, while CMVLF trades at $3.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas CMVLF's P/E ratio is -4.60. In terms of profitability, IVBXF's ROE is +0.05%, compared to CMVLF's ROE of -0.70%. Regarding short-term risk, IVBXF and CMVLF have similar daily volatility (0.00).Check CMVLF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, SPHRY has a market cap of 218.9M. Regarding current trading prices, IVBXF is priced at $11.45, while SPHRY trades at $5.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas SPHRY's P/E ratio is -86.67. In terms of profitability, IVBXF's ROE is +0.05%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, IVBXF is less volatile compared to SPHRY. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check SPHRY's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, IVBXF is priced at $11.45, while FPHAF trades at $3.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, IVBXF's ROE is +0.05%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, IVBXF and FPHAF have similar daily volatility (0.00).Check FPHAF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, RECEF has a market cap of 182.6M. Regarding current trading prices, IVBXF is priced at $11.45, while RECEF trades at $0.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas RECEF's P/E ratio is -8.33. In terms of profitability, IVBXF's ROE is +0.05%, compared to RECEF's ROE of +2.79%. Regarding short-term risk, IVBXF is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check RECEF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, KNTPF has a market cap of 172.3M. Regarding current trading prices, IVBXF is priced at $11.45, while KNTPF trades at $0.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas KNTPF's P/E ratio is -6.12. In terms of profitability, IVBXF's ROE is +0.05%, compared to KNTPF's ROE of -0.63%. Regarding short-term risk, IVBXF and KNTPF have similar daily volatility (0.00).Check KNTPF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, IVBXF is priced at $11.45, while ADOCY trades at $11.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, IVBXF's ROE is +0.05%, compared to ADOCY's ROE of +8.60%. Regarding short-term risk, IVBXF and ADOCY have similar daily volatility (0.00).Check ADOCY's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, BRIBF has a market cap of 166.6M. Regarding current trading prices, IVBXF is priced at $11.45, while BRIBF trades at $0.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas BRIBF's P/E ratio is -4.62. In terms of profitability, IVBXF's ROE is +0.05%, compared to BRIBF's ROE of -0.09%. Regarding short-term risk, IVBXF is less volatile compared to BRIBF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check BRIBF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, BBIXF has a market cap of 151.8M. Regarding current trading prices, IVBXF is priced at $11.45, while BBIXF trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas BBIXF's P/E ratio is -13.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to BBIXF's ROE of -15.41%. Regarding short-term risk, IVBXF and BBIXF have similar daily volatility (0.00).Check BBIXF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, SCNLF has a market cap of 151.1M. Regarding current trading prices, IVBXF is priced at $11.45, while SCNLF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas SCNLF's P/E ratio is -14.56. In terms of profitability, IVBXF's ROE is +0.05%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, IVBXF and SCNLF have similar daily volatility (0.00).Check SCNLF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, JWCTF has a market cap of 147.8M. Regarding current trading prices, IVBXF is priced at $11.45, while JWCTF trades at $0.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas JWCTF's P/E ratio is -1.78. In terms of profitability, IVBXF's ROE is +0.05%, compared to JWCTF's ROE of -0.75%. Regarding short-term risk, IVBXF is less volatile compared to JWCTF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check JWCTF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, SPHRF has a market cap of 147.3M. Regarding current trading prices, IVBXF is priced at $11.45, while SPHRF trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas SPHRF's P/E ratio is -35.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, IVBXF and SPHRF have similar daily volatility (0.00).Check SPHRF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, TRGNF has a market cap of 144.2M. Regarding current trading prices, IVBXF is priced at $11.45, while TRGNF trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas TRGNF's P/E ratio is -3.03. In terms of profitability, IVBXF's ROE is +0.05%, compared to TRGNF's ROE of -0.64%. Regarding short-term risk, IVBXF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check TRGNF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, AMGXF has a market cap of 142.5M. Regarding current trading prices, IVBXF is priced at $11.45, while AMGXF trades at $0.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, IVBXF's ROE is +0.05%, compared to AMGXF's ROE of -0.45%. Regarding short-term risk, IVBXF is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check AMGXF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, IPHYF has a market cap of 140.7M. Regarding current trading prices, IVBXF is priced at $11.45, while IPHYF trades at $1.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas IPHYF's P/E ratio is -2.31. In terms of profitability, IVBXF's ROE is +0.05%, compared to IPHYF's ROE of +5.94%. Regarding short-term risk, IVBXF and IPHYF have similar daily volatility (0.00).Check IPHYF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, HBPCF has a market cap of 132.1M. Regarding current trading prices, IVBXF is priced at $11.45, while HBPCF trades at $1.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas HBPCF's P/E ratio is -43.25. In terms of profitability, IVBXF's ROE is +0.05%, compared to HBPCF's ROE of -0.37%. Regarding short-term risk, IVBXF and HBPCF have similar daily volatility (0.00).Check HBPCF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, IVBXF is priced at $11.45, while AAPGV trades at $17.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas AAPGV's P/E ratio is N/A. In terms of profitability, IVBXF's ROE is +0.05%, compared to AAPGV's ROE of -1.24%. Regarding short-term risk, IVBXF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check AAPGV's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, IVBXF is priced at $11.45, while PSTTF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to PSTTF's ROE of N/A. Regarding short-term risk, IVBXF and PSTTF have similar daily volatility (0.00).Check PSTTF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, ATGGF has a market cap of 113.5M. Regarding current trading prices, IVBXF is priced at $11.45, while ATGGF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas ATGGF's P/E ratio is N/A. In terms of profitability, IVBXF's ROE is +0.05%, compared to ATGGF's ROE of -1.34%. Regarding short-term risk, IVBXF is less volatile compared to ATGGF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check ATGGF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, IVBXF is priced at $11.45, while EPRXF trades at $3.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, IVBXF's ROE is +0.05%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, IVBXF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check EPRXF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, POLBF has a market cap of 106.5M. Regarding current trading prices, IVBXF is priced at $11.45, while POLBF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas POLBF's P/E ratio is -7.55. In terms of profitability, IVBXF's ROE is +0.05%, compared to POLBF's ROE of -0.54%. Regarding short-term risk, IVBXF is less volatile compared to POLBF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check POLBF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, IVBXF is priced at $11.45, while ADOIF trades at $8.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, IVBXF's ROE is +0.05%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, IVBXF and ADOIF have similar daily volatility (0.00).Check ADOIF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, MSCLF has a market cap of 96.6M. Regarding current trading prices, IVBXF is priced at $11.45, while MSCLF trades at $6.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas MSCLF's P/E ratio is 2.43. In terms of profitability, IVBXF's ROE is +0.05%, compared to MSCLF's ROE of -0.70%. Regarding short-term risk, IVBXF is less volatile compared to MSCLF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check MSCLF's competition here

IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IVBXF stands at 19.7B. In comparison, NDTP has a market cap of 92.8M. Regarding current trading prices, IVBXF is priced at $11.45, while NDTP trades at $0.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IVBXF currently has a P/E ratio of 163.57, whereas NDTP's P/E ratio is -2.90. In terms of profitability, IVBXF's ROE is +0.05%, compared to NDTP's ROE of -0.33%. Regarding short-term risk, IVBXF and NDTP have similar daily volatility (0.00).Check NDTP's competition here